These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 34765583)

  • 1. Combatting Substandard and Falsified Medicines: Public Awareness and Identification of Counterfeit Medications.
    El-Dahiyat F; Fahelelbom KMS; Jairoun AA; Al-Hemyari SS
    Front Public Health; 2021; 9():754279. PubMed ID: 34765583
    [No Abstract]   [Full Text] [Related]  

  • 2. Point-of-Care Anti-Counterfeit Medicines Technologies: Awareness and Utilization among Medical Practitioners in Eastern Nigeria.
    Iloh GU; Akodu BA; Emeka EA; Obi IV
    West Afr J Med; 2021 Nov; Vol. 38(11):1029-1035. PubMed ID: 34918894
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Assessment of knowledge, attitude, and practice on substandard and counterfeit pharmaceutical products among pharmacy professionals in Gondar City, North-West Ethiopia.
    Worku MC; Mitku ML; Ayenew W; Limenh LW; Ergena AE; Geremew DT; Bizuneh GK; Tefera BB; Mekonnen BA; Anagaw YK
    Curr Pharm Teach Learn; 2024 Oct; 16(10):102140. PubMed ID: 39002340
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A cross-sectional analysis of falsified, counterfeit and substandard medicines in a low-middle income country.
    Khurelbat D; Dorj G; Sunderland B; Sanjjav T; Bayarsaikhan E; Damdinjav D; Dorj G; Jigjidsuren A; Lkhagvasuren O; Erdenetsetseg B
    BMC Public Health; 2020 May; 20(1):743. PubMed ID: 32434489
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Community pharmacists' knowledge of substandard and falsified medicines in clinical practice: a cross-sectional survey in Saudi Arabia.
    Bashayr Ali A; Barrett R
    Int J Pharm Pract; 2023 Apr; 31(2):176-182. PubMed ID: 36748987
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of pharmacists in eliminating counterfeit medicines in Nigeria.
    Adigwe OP
    Front Public Health; 2023; 11():1170929. PubMed ID: 37674683
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Community pharmacists' perceptions, awareness and practices regarding counterfeit medicines: a cross-sectional survey in Alexandria, Egypt.
    Bashir A; Galal S; Ramadan A; Wahdan A; El-Khordagui L
    East Mediterr Health J; 2020 May; 26(5):556-564. PubMed ID: 32538449
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fighting trafficking of falsified and substandard medicinal products in Russia.
    Fayzrakhmanov NF
    Int J Risk Saf Med; 2015; 27 Suppl 1():S37-40. PubMed ID: 26639702
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of community pharmacists' readiness to implement the Falsified Medicines Directive (Directive 2011/62/EC): an English cross-sectional survey with geospatial analysis.
    Barrett R
    BMJ Open; 2020 Jan; 10(1):e033405. PubMed ID: 31924640
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Surveillance for falsified and substandard medicines in Africa and Asia by local organizations using the low-cost GPHF Minilab.
    Petersen A; Held N; Heide L;
    PLoS One; 2017; 12(9):e0184165. PubMed ID: 28877208
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Health Care Providers' Knowledge, Attitude and Practice Toward Counterfeit Medicines in Mizan-Tepi University Teaching Hospital, South West Ethiopia: A Cross-Sectional Study.
    Siraj J; Gebre A; Shafi M; Birhan A; Ejeta F; Hambisa S
    Inquiry; 2022; 59():469580221108335. PubMed ID: 35942588
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of Substandard and Falsified Medicines: Influence of Different Tolerance Limits and Use of Authenticity Inquiries.
    Hauk C; Hagen N; Heide L
    Am J Trop Med Hyg; 2021 Mar; 104(5):1936-1945. PubMed ID: 33788775
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Falsified Drugs in the Opinion of Patients Diagnosed with Cardiovascular Diseases-Nationwide and Cross-Sectional Study on the Example of EU-Member Country.
    Świeczkowski D; Zdanowski S; Merks P; Jaguszewski M
    Int J Environ Res Public Health; 2021 Apr; 18(7):. PubMed ID: 33917444
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Assessment of the effectiveness of the CD3+ tool to detect counterfeit and substandard anti-malarials.
    Batson JS; Bempong DK; Lukulay PH; Ranieri N; Satzger RD; Verbois L
    Malar J; 2016 Feb; 15():119. PubMed ID: 26917250
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Global perspective of the risks of falsified and counterfeit medicines: A critical review of the literature.
    Feeney AJ; Goad JA; Flaherty GT
    Travel Med Infect Dis; 2024; 61():102758. PubMed ID: 39218049
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Substandard and Falsified Medicines: Proposed Methods for Case Finding and Sentinel Surveillance.
    Pisani E; Hasnida A; Rahmi M; Kok MO; Harsono S; Anggriani Y
    JMIR Public Health Surveill; 2021 Aug; 7(8):e29309. PubMed ID: 34181563
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Public health interventions to protect against falsified medicines: a systematic review of international, national and local policies.
    Hamilton WL; Doyle C; Halliwell-Ewen M; Lambert G
    Health Policy Plan; 2016 Dec; 31(10):1448-1466. PubMed ID: 27311827
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Substandard and falsified medical products are a global public health threat. A pilot survey of awareness among physicians in Sweden.
    Funestrand H; Liu R; Lundin S; Troein M
    J Public Health (Oxf); 2019 Mar; 41(1):e95-e102. PubMed ID: 29860331
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The development and appraisal of a tool designed to find patients harmed by falsely labelled, falsified (counterfeit) medicines.
    Anđelković M; Björnsson E; De Bono V; Dikić N; Devue K; Ferlin D; Hanževački M; Jónsdóttir F; Shakaryan M; Walser S
    BMC Health Serv Res; 2017 Jun; 17(1):419. PubMed ID: 28633634
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Legal aspects of counteracting the trafficking of falsified medicines in the european union.
    Pashkov V; Soloviov A; Olefir A
    Wiad Lek; 2017; 70(4):843-849. PubMed ID: 29064815
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.